Compare · MCK vs SNYR
MCK vs SNYR
Side-by-side comparison of McKesson Corporation (MCK) and Synergy CHC Corp. (SNYR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MCK and SNYR operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- MCK is the larger of the two at $105.52B, about 70822.6x SNYR ($1.5M).
- Over the past year, MCK is up 33.2% and SNYR is down 95.9% - MCK leads by 129.0 points.
- MCK has been more active in the news (8 items in the past 4 weeks vs 3 for SNYR).
- MCK has more recent analyst coverage (25 ratings vs 2 for SNYR).
- Company
- McKesson Corporation
- Synergy CHC Corp.
- Price
- $905.22+3.56%
- $0.10-6.80%
- Market cap
- $105.52B
- $1.5M
- 1M return
- +6.39%
- -45.11%
- 1Y return
- +33.20%
- -95.85%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2024
- News (4w)
- 8
- 3
- Recent ratings
- 25
- 2
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest MCK
- McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
- RBC Capital Mkts initiated coverage on McKesson with a new price target
- SEC Form 4 filed by EVP and Chief Strategy Officer Srinivasan Ramesh (Nmn)
- Director Lerman Bradley E sold $268,590 worth of shares (301 units at $892.33), closing all direct ownership in the company (SEC Form 4)
- New insider Srinivasan Ramesh (Nmn) claimed ownership of 11,959 shares (SEC Form 3)
- SEC Form 10-Q filed by McKesson Corporation
- McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance
- McKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- McKesson Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Director Hinton James H.
Latest SNYR
- Synergy CHC Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
- Synergy CHC Corp. Announces Receipt of Nasdaq Letter
- Synergy CHC Corp. filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation
- Synergy CHC Corp. filed SEC Form 8-K: Other Events
- SEC Form 4 filed by President Baumeler Alfred
- SEC Form 4 filed by Chief Financial Officer Fickett Jaime
- SEC Form 4 filed by CEO and Chairman Ross Jack
- Synergy CHC Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form EFFECT filed by Synergy CHC Corp.
- Synergy CHC Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing